Insiders · Profile

Goyal Vikas

Director at Spero Therapeutics. Filing since 6 Nov 2017. CIK 0001721017

Company

Date

Role

Action

Shares

Amount

Of holding

SPRO Spero Therapeutics, Inc.

6 Nov 2017

Director

Bought

428,571

$6.00M

30.1%

1 decision on file.